| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
O-2093 manufacturers
- O-2093
-
-
2026-07-01
- CAS:439080-01-0
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 20Tons
- O-2093
-
- $2180.00
-
2026-05-11
- CAS:439080-01-0
- Purity:
- Supply Ability: 10g
|
| Product Name: | O-2093 | | Synonyms: | O-2093;N-(BIS-3-CHLORO-4-HYDROXYBENZYL)-5Z,8Z,11Z,14Z-EICOSATETRAENAMIDE;5,8,11,14-Eicosatetraenamide, N,N-bis[(3-chloro-4-hydroxyphenyl)methyl]-, (5Z,8Z,11Z,14Z)-;O2093,O 2093;(5Z,8Z,11Z,14Z)-N,N-Bis(3-chloro-4-hydroxybenzyl)icosa-5,8,11,14-tetraenamide | | CAS: | 439080-01-0 | | MF: | C34H43Cl2NO3 | | MW: | 584.62 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | O-2093 Chemical Properties |
| storage temp. | Desiccate at -20°C | | solubility | Soluble in ethanol (supplied pre-dissolved in anhydrous ethanol, 5mg/ml) | | form | Powder |
| | O-2093 Usage And Synthesis |
| Uses | O-2093 is an inhibitor of anandamide uptake. | | Biological Activity | Inhibitor of anandamide uptake (IC 50 = 17.3 μ M) with little or no activity at CB 1 , CB 2 , TRPV1 and FAAH. Intravenous administration inhibits limb spasticity in mice with chronic relapsing experimental allergic encephalomyelitis (CREAE). | | in vivo | O-2093 (1 mg/kg, i.v.) can significantly inhibit limb spasticity in CREATE mice[1].
|
| | O-2093 Preparation Products And Raw materials |
|